Jefferies Downgrades Medpace Hldgs to Hold, Lowers Price Target to $345
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst David Windley has downgraded Medpace Holdings (NASDAQ:MEDP) from Buy to Hold and reduced the price target from $415 to $345.
September 25, 2024 | 1:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Jefferies has downgraded Medpace Holdings from Buy to Hold, with a reduced price target of $345, indicating a less optimistic outlook.
The downgrade from Buy to Hold by Jefferies suggests a less favorable view on Medpace's future performance. The lowered price target from $415 to $345 indicates reduced expectations for the stock's potential upside, likely leading to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100